BioCentury
ARTICLE | Clinical News

Hera Therapeutics preclinical data

September 22, 2014 7:00 AM UTC

In cultured human cell models, HTI-1968 blocked the replication of HPV types 11, 16, and 18 cells. Data were presented at the International Papillomavirus Conference in Seattle. HTI-1968 is a topical ...